BIG CHANGES ARE COMING TO YOUR OTP, starting this October.

SAMHSA Webinar Recordings on 42 CFR Part 8,

Clinical & Administrative

AATOD is pleased to share the March 20th and March 27th webinar recordings.

Please see below for descriptions and access to the recording links.

On February 2, 2024, the final rule for 42 CFR Part 8 was published. The effective date for these regulations is April 2, 2024, with an implementation date of October 2, 2024. 

In preparation for implementation of the revisions, SAMHSA provided two preliminary webinars for OTPs.  The first focused on administrative areas (March 20th); the second (March 27th) focused more on clinical content.  These presentations were followed by Q&A.

These webinars provided an overview of the rule changes and provided a discussion with SAMHSA regarding the implications of the changes. 

We encourage you to view these recordings to assist you in determining how you will need to prepare for full implementation of these regulations. 

This webinar series was moderated by Mark W. Parrino, MPA (AATOD President). Speakers included Yngvild Olsen, MD, MPH (Director - CSAT), Robert Baillieu, MD, MPH, FAAFP (Physician and Senior Advisor - SAMHSA/CSAT, and Patti Juliana, PhD, LCSW

(Director - CSAT’s Division of Pharmacologic Therapies).

SAMHSA Webinar on 42 CFR Part 8 - Administrative

SAMHSA Webinar on 42 CFR Part 8, Clinical

Speaker Biographies

Mark W. Parrino, MPA (Moderator) has been involved in the delivery of health care and substance abuse treatment since 1974. He received both a Baccalaureate in Psychology (1974) and a Masters in Health Policy, Planning and Administration (1982) from New York University.

Mr. Parrino served as the Director of the Gramercy Park Medical Group, an outpatient methadone treatment program, from 1980 to 1994. He also served as President of the National Development and Research Institutes, Inc. (NDRI) and was the Chair of New York City’s Health Systems Agency’s Technical Advisory Group on Substance Abuse.

Mr. Parrino served as the Chair of the Center for Substance Abuse Treatment (CSAT) Consensus Panel for State Methadone Treatment Guidelines, the first Treatment Improvement Protocol (TIP) published for national distribution.

Currently, Mr. Parrino is the President of the American Association for the Treatment of Opioid Dependence and continues to be responsible for the development and implementation of the Association’s organizing initiatives. He is a consultant and educator to government, community and business groups concerning substance abuse treatment and policy. Mr. Parrino is a recipient of the Robert Wood Johnson Foundation Innovators Award for 2003.

Yngvild Olsen, MD, MPH, serves as the Director for the Center for Substance Abuse Treatment (CSAT). She has a long history of working within the addiction treatment field to expand access to care and enhance quality. She began her career as the Medical Director for the Johns Hopkins Hospital’s outpatient substance use treatment services while a full-time Assistant Professor in the Department of Medicine at the Johns Hopkins School of Medicine. She subsequently served as the Deputy Health Officer for Maryland’s Harford County Health Department, where she led a modernization of publicly funded substance use treatment services in collaboration with State and local partners. She next served as the Vice President of Clinical Affairs for the Baltimore Substance Abuse Systems, then the local addiction authority for Baltimore City. In that position, she played a central role in the expansion of buprenorphine treatment for opioid addiction in both specialty treatment and general ambulatory medical systems From 2011 to 2021, she served as Medical Director for the Institutes for Behavior Resources/REACH Health Services, a comprehensive outpatient substance use disorder treatment program in Baltimore City. After graduating from Harvard Medical School, Dr. Olsen completed residency training in internal medicine and served as primary care chief resident at Boston Medical Center. She completed a Fellowship in General Internal Medicine at Johns Hopkins, during which time she received a Master in Public Health degree from the Johns Hopkins Bloomberg School of Public Health. 

Robert Baillieu, MD, MPH, FAAFP, serves as a physician and senior advisor at the Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT). He graduated with honors from the University of Sydney Medical School in Australia and completed residency training in family medicine at The University of Texas Health Science Center in San Antonio, where he was also chief resident. Prior to this, Dr. Baillieu lived in Australia where he undertook training in adult internal medicine. He is a board-certified family physician, fellow of the American Academy of Family Physicians, and a former Robert L. Phillips, Jr., Health Policy Fellow at the American Academy of Family Physicians’ Robert Graham Center and the U.S. Health Resources and Services Administration, Bureau of Primary Care. He holds degrees in medicine, public health, business, and modern languages, and he has experience in health systems research, policy analysis, community organizing, international business, management, public health, education, and medical practice. Dr. Baillieu is also a former assistant professor of clinical family medicine at Georgetown University where he supervised residents and taught classes in policy, advocacy, statistics, and clinical medicine. Dr. Baillieu’s research activities have focused on the primary care workforce, health IT, and the implementation of best practices at the community level. He has presented at national and international meetings and has published in international, peer-reviewed journals.

Patti Juliana, PhD, LCSW, is the Director for CSAT’s Division of Pharmacologic Therapies. She has extensive clinical and administrative experience in opioid treatment services and has led a continuum of inpatient and outpatient SUD prevention and treatment services in hospital and community-based settings. She has served as an OTP accreditation surveyor and provided technical assistance to OTPs and states on provision of quality OTP services and implementation of evidence-based practices. Throughout her career, she has integrated comprehensive SUD treatment services and general medical services to reduce barriers to service delivery and improve access to care. Her commitment to workforce development is evidenced by her having served on New York state’s counselor credentialing and peer certification boards, facilitation of placement of students in SUD treatment services, staff training, and teaching in MSW programs. She is a clinical social worker licensed in New York and a certified trauma professional.

Get social with AATOD, @aatod1984.